Wordt geladen...
Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with major depressive disorder offer the hope of a new era in treating mood and anxiety...
Bewaard in:
| Gepubliceerd in: | Neurobiol Stress |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6804800/ https://ncbi.nlm.nih.gov/pubmed/31649968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ynstr.2019.100196 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|